---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-120273"
form_type: "8-K"
ticker: null
cik: "0001808865"
company_name: "iTeos Therapeutics, Inc."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:14:35.254128+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Board member Aaron Davis resigns from iTeos Therapeutics, effective Nov 1

## Summary
- Aaron Davis resigned from the Board of Directors on Oct 31, effective Nov 1, 2024.
- Resignation was not due to any disagreement with the Company, management, or Board.
- No replacement has been announced; Board seat is now vacant.

## SEC filing metadata
- accession: 0000950170-24-120273
- form_type: 8-K
- cik: 0001808865
- company_name: iTeos Therapeutics, Inc.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808865/000095017024120273/0000950170-24-120273-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808865/000095017024120273/itos-20241031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-120273
- JSON: https://secwatch.observer/filing/0000950170-24-120273.json
- Plain text: https://secwatch.observer/filing/0000950170-24-120273.txt

## Key facts
- Executive change
  Aaron Davis resigned as member of the Board of Directors at iTeos Therapeutics, Inc..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On October 31, 2024, Aaron Davis, a member of the Board of Directors (the “ Board ”) of iTeos Therapeutics, Inc. (the “ Company ”), resigned from the Board, effective November 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808865/000095017024120273/0000950170-24-120273-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.